Andrew Manganaro is the CMO at Life Line Screening. His idea to start Life Line Screening came as a result of his experiences as a cardiovascular surgeon. He experienced several cases of asymptomatic diseases turned catastrophic because the victims had not been aware of the asymptomatic conditions. He, therefore, started LLC as a means to help in identification of the asymptomatic diseases through screening and read full article.
Life Line Screening
As of today, Life Line Screening is America’s largest company involved in screening vascular diseases and those associated with it. According to Doctor Manganaro, there have been over 8 million people screened, and Life Line Screening have a large database of peer-reviewed journals worldwide. His role as CMO is to ensure quality and supervise the certified physicians reviewing the patient ultrasounds. He also plays a major role in chairing the Scientific Advisory Network that comprises prominent academicians and specialists in the medical world. Life Line Screening goes beyond the normal measures of an annual checkup by making use of risk algorithms to determine a patient’s suitability for screening. In this way, they not only offer screening for individuals at risk of cardiovascular diseases but also those who are asymptomatic and learn more about Lifeline Screening.
Types of screening provided by Life Line Screening
Life Line Screening offers three types of preventive health screenings:
Finger-Stick Blood Screenings help in the identification of risk factors for diabetes and heart disease. LLS uses FDA approved, accurate lab instruments to prick the finger’s soft pad and draw a few drops of blood. The results of the test come back to the patient in averagely ten minutes. LLS also offers ultrasound screening through which they transmit sound waves to a particular area of the body, and the echoes of the sound are recorded. The history of the ultrasound is interesting as it was first used to locate objects that got submerged in water during the Second World War. Today, it is used to track the development of fetuses and to detect various conditions including cardiology, obstetrics, and ophthalmology. The limited Electrograph is also a type of screening used to detect irregular heartbeats which may increase the risk of stroke and Lifeline Screening’s lacrosse camp.
More visit: http://www.lifelinescreening.com/results
Mikhail Blagosklonny is a well known oncologist and scientist who studies the effect that cancer and aging has on the human body. He attended the First Pavlov State Medical University of St. Petersburg and possesses both a M.D. in internal medicine and his PhD in experimental medicine and cardiology. Soon after graduating Blagosklonny took a job at New York Medical College as the associate professor of medicine. He has also held major positions in other prominent medical institutions including, the Ordway Research Institute and Roswell Park Cancer Institute. He has served as the Professor of Oncology at Roswell for 8 years. Being a professor came easy to Blagosklonny. He was able to draw on the information he’d gathered in past intervals of his career.
As a scientist he has come up with a hypothesis regarding TOR (target of Rapamycin) Signaling potential role in cancer and aging. Rapamycin is a drug commonly used to treat cancer. His strong belief in Rapamycin being an effective cancer drug has led to him being deemed as one of the most passionate advocates of Rapamycin for long term use. He works for Oncotarget and Cell Cycle as the editor-in-chief. He serves as the associate editor of cancer biology and therapy as well as, associate editor for PLOS ONE, the American Journal of Pathology, and International Journal of Cancer. Read more on templeofthecave.com
Blagosklonny is an author of aging hyperfunction theory. He has written and published a few hundred research articles and reviews. His subject mater includes medical treatments like cell cyclotherapy and chemotherapeutic engineering. He is adamant in his belief that aging can be controlled and cancer can be cured.
Oncologist like Mikhail Blagosklonny give hope to those suffering from cancer. If more people were as positive and driven as him the cancer might’ve been a non-lethal illness by now.
Know more: https://www.crunchbase.com/person/mikhail-blagosklonny
What is Oncotarget?
The field of oncology is broad, and there are millions of published journals about the topic. It’s not always easy for researchers and students to find the correct piece of data and information they are searching for. What that does is that it slows down progress. It would have been much easier had the researchers been on the same page as opposed to them working with their own assumptions.
Two academics, Andrei V. Gudkov and Mikhail Blagosklonny, saw a lucrative opportunity in this shortfall. They decided to come up with Oncotarget. This would be a resource medical research information portal with a free commons license permit. The central area of medicine covered on the website would be on proposed treatments, vaccines and the latest research study findings on the race for the cure to cancer.
Using the Oncotarget Site
The resource hub, Oncotarget became an instant hit especially with both leading oncology researchers and medical students. In a matter of months, the traffic to the site had continued to grow steadily by astonishing leaps and bounds. A casual visit to the website reveals just how intuitive the designers must have been. Well, for starters, everything you need is in plain sight. There are ‘Search’ functions boxes to use when looking up particular research papers. The Indexing of the journals is done to meet international standards and therefore, it is very easy to follow through with the background content behind the particular oncology findings. Read more about Oncotarget at Bioxbio.
Meet the Editors
The hand-picked editorial team working at Oncotarget is an exceptional bunch. They are all masters when it comes to picking up errors and flaws in medical writings. So far, the editors have produced well over two dozen papers which have gone ahead to be accepted by their peers upon reviewing. The four writers who started the firm back in 2013 shared the prestigious, Breakthrough Prize for their extraordinary accomplishments.
Learn more: http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget
Check out Oncotargets’ site and pore over the enlightening interviews with the top-rated authors on this platform. If you are an aspiring medical writer, then there ought to be tons of nifty and witty ideas you can pick up to give your pursuits a sure boost. Subscribe and get the latest stories sent straight to your personal email address. Researchers have no option but to bookmark the site. On top of it all. Oncotarget is also available on Dove Press.